Most are highly infiltrated by immune cells, but there are also MSI-H CRCs with low immune infiltration that are associated with mucinous histology, KRAS mutations and Wnt/Notch activation, greater tumor size, distant metastasis or early recurrence. This evidence concerns the gene KRAS and neoplasm.